| Professor Matt Murray is a Professor and Honorary Consultant Paediatric Oncologist, in the Department of Pathology, Cambridge University and Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, United Kingdom. He has a particular interest in the clinical and molecular aspects of germ cell tumours (GCTs), and was the first to demonstrate the potential utility of specific circulating microRNAs for diagnosis, disease-monitoring and detection of relapse in this disease. He has attracted >£4M of grant funding to date as a Principal and Co-Investigator. He has demonstrated leadership in GCT biology at national and international levels through his involvement the MaGIC Consortium, a UK-US led initiative developing international trials of extracranial GCTs in children, adolescents & young adults, including embedded biological studies. He is a member of the International Society of Paediatric Oncology (SIOP-Europe) Brain Tumour Group – GCT Subgroup the National Cancer Research Institute (NCRI) Children’s Cancer and Leukaemia Clinical Studies Group, the GCT Subgroup, the National Cancer Research Institute (NCRI) Testis Cancer Clinical Studies Group and the Co-Lead of the 100,000 Genomes Project (GeCIP) Testis Cancer Domain. |
Professor Matt Murray
Paediatric Oncologist and Professor, University of Cambridge (Cambridge)
